Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc Price Chart RYTM

Historical daily share price chart and data for Rhythm Pharmaceuticals Inc since 2017 adjusted for splits and dividends. The latest closing price for Rhythm Pharmaceuticals Inc as of September 13, 2019 is $23.85.
  • In 2019 the stock opened at $26.50 and closed at $23.85 for a loss of -11% YTD.
  • In 2018 the stock opened at $28.94 and closed at $26.88 for a loss of -8%.
  • In 2017 the stock opened at $23.21 and closed at $29.06 for a gain of 20%.
View Chart On Koyfin

Rhythm Pharmaceuticals Inc Summary

Stock Symbol: RYTM

Rhythm Pharmaceuticals Inc Company Info

Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic disorders that result in life-threatening metabolic disorders. The company’s lead product candidate is setmelanotide, a melanocortin-4 receptor agonist peptide, which is in Phase III clinical trials to treat pro-opiomelanocortin (POMC) and leptin receptor deficiency obesity, and Bardet-Biedl and Alström syndrome; and is in Phase II clinical trials for treating POMC heterozygous deficiency obesity and POMC epigenetic disorders. It is also developing RM-853, an orally available ghrelin o-acyltransferase inhibitor that is in preclinical development for Prader-Willi syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Market Cap
823.2m
Dividend Yield
0 %
Beta vs SPX
1.55
Short Interest
258.77 %
30D Volatility
42.1
Hedge Fund Held
0 %
Competitors

Last 10 Days of RYTM Prices

09/13/2019$23.85
09/12/2019$22.94
09/11/2019$23.02
09/10/2019$21.28
09/09/2019$21.44
09/06/2019$20.51
09/05/2019$21.00
09/04/2019$21.91
09/03/2019$22.49
08/30/2019$22.52